EDRH
ZBIO

Edmond de Rothschild Holding’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History

Edmond de Rothschild Holding’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-42,233
Closed -$1.78M – 905
2016
Q3 		$1.78M Buy
+42,233
New +$1.95M 0.05% 204

Other funds holding ZBIO

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Edmond de Rothschild Holding's ZBIO Position: Q4 2016 in Review

Edmond de Rothschild Holding sold out of ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) in Q4 2016, closing a stake of 42,233 shares — an estimated $1.78M sold.

Edmond de Rothschild Holding first reported a position in ZBIO in Q3 2016 and held it in 1 quarter. The position peaked at $1.78M in Q3 2016. 3 funds tracked by Wall St. Rank hold ZBIO as of Q4 2016.

  • Edmond de Rothschild Holding reported no remaining ProShares UltraPro Short NASDAQ Biotechnology position as of Q4 2016 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 42,233 ProShares UltraPro Short NASDAQ Biotechnology shares in Q4 2016, an estimated $1.78M.
  • Edmond de Rothschild Holding first reported a position in ProShares UltraPro Short NASDAQ Biotechnology in Q3 2016 and held it in 1 quarter.
  • Edmond de Rothschild Holding's ProShares UltraPro Short NASDAQ Biotechnology position peaked at $1.78M in Q3 2016.
  • 3 funds tracked by Wall St. Rank held ProShares UltraPro Short NASDAQ Biotechnology as of Q4 2016.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2016, filed 14 Feb 2017.